Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Doppl SA logo — Personalised medicine - for everyone

Doppl SA

Personalised medicine - for everyone

Founded 2022 Switzerland Lausanne, Switzerland 16 employees Debt Financing Total: $600.00K Health Care

General Information

Company Name Doppl SA
Founded Year 2022
Location Switzerland Lausanne, Switzerland
Employees 16
Industries Health Care
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Doppl SA. To contact Doppl SA, visit doppl.ch.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Doppl SA compare?

A PDF of Doppl SA and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Doppl SA soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Doppl SA

Doppl SA is a Switzerland-based startup focused on personalized medicine with the slogan "Personalised medicine - for everyone." Established in 2022, Doppl SA is a spin out of SUN bioscience SA and is recognized for its expertise in engineering industry-standard organoids for disease modeling and personalized medicine. The company collaborates on partnered projects for preclinical drug development, offering relevant, high-quality, and scalable organoid models. Its latest investment of Fr.500.00K in debt financing was secured on 22 January 2024, with the Foundation for Technological Innovation (FIT) as the investing entity. Operating in the Health Care sector, Doppl SA demonstrates promising potential in the intersection of biotechnology and healthcare.

Business keywords: personalized medicine, organoid engineering, disease modeling, preclinical drug development, biobank, medical research, citizen-led research, drug development, spin out, SUN bioscience SA, DOPPL SA, partnered projects, scalable organoid models, crowd-sourced biobank, high-quality organoids

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing Fr.500.00K 1
Foundation for Technological Innovation (FIT)
22 Jan 2024
Debt Financing Fr.100.00K 1
Foundation for Technological Innovation (FIT)
21 Sep 2022

Doppl SA Alternatives & Competitors

View All Alternatives
Doppl SA vs
Monument Therapeutics
Monument Therapeutics United Kingdom

Bringing Precision Medicine to Neuroscience Drug Development

Venture round
6 employees
Biotechnology, Health Care
Doppl SA vs
Emulate, Inc.
Emulate, Inc. United States

Our Organ-on-a-Chip technology provides a high-fidelity window into the inner workings of human biol...

Series F
71 employees
Biotechnology, Health Care
Doppl SA vs
StemoniX
StemoniX United States

Pre-plated, human iPSC-derived microOrgans for toxicology and drug discovery research

Convertible Note
1 employees
Biotechnology, Health Care
View all alternatives

FAQ About Doppl SA

Personalised medicine - for everyone
Doppl SA was founded in 2022.
Doppl SA is headquartered in Lausanne, Switzerland.
Doppl SA operates in Health Care. Its work centres on personalized medicine, organoid engineering, disease modeling and preclinical drug development.
Doppl SA has approximately 16 employees.
Doppl SA has completed 2 funding rounds, raising a total of $600.00K. The latest funding stage is Debt Financing.
Top alternatives and competitors to Doppl SA include Monument Therapeutics, Emulate, Inc., StemoniX, MesenFlow Technologies SARL, MICA Biosystems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Doppl SA and Monument Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Doppl SA, https://bouncewatch.com/company/doppl-sa, updated 4 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes